Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis.

Front Immunol · 2026 · PMC13260096 · PMID 42292353

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Based on the data from this meta-analysis, the 10 mg/kg Q3W regimen showed a trend towards relatively superior efficacy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.